Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,209,281 papers from all fields of science
Search
Sign In
Create Free Account
KIAA1524 wt Allele
Known as:
Autoantigen, 90-kD Gene
, CIP2A
, p90
Human KIAA1524 wild-type allele is located in the vicinity of 3q13.13 and is approximately 44 kb in length. This allele, which encodes protein CIP2A…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Broader (1)
KIAA1524 gene
Stimulation of Cell Proliferation
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
High CIP2A levels correlate with an antiapoptotic phenotype that can be overcome by targeting BCL-XL in chronic myeloid leukemia
C. Lucas
,
M. Milani
,
+5 authors
S. Varadarajan
Leukemia
2016
Corpus ID: 14187825
Cancerous inhibitor of protein phosphatase 2A (CIP2A) is a predictive biomarker of disease progression in many malignancies…
Expand
2015
2015
c-Myc inhibition decreases CIP2A and reduces BCR-ABL1 tyrosine kinase activity in chronic myeloid leukemia
C. Lucas
,
Robert J. Harris
,
A. Giannoudis
,
R. Clark
Haematologica
2015
Corpus ID: 32099278
Chronic myeloid leukemia (CML) is a malignant disease of the primitive hematologic cell which is driven by BCR-ABL1 tyrosine…
Expand
2014
2014
CIP2A is overexpressed in osteosarcoma and regulates cell proliferation and invasion
Mo Zhai
,
L. Cong
,
Yaxin Han
,
G. Tu
Tumor Biology
2014
Corpus ID: 17547921
Cancerous inhibitor of protein phosphatase 2A (CIP2A) is a newly characterized oncoprotein involved in a variety of malignant…
Expand
2014
2014
Expression patterns of microRNA-218 and its potential functions by targeting CIP2A and BMI1 genes in melanoma
Yanping Wei
,
Yuwen Du
,
+6 authors
Guoqiang Zhao
Tumor Biology
2014
Corpus ID: 17000202
Melanoma is the most aggressive skin cancer, and it is typically resistant or rapidly develops resistance to a variety of…
Expand
2013
2013
Chk1 targeting reactivates PP2A tumor suppressor activity in cancer cells.
A. Khanna
,
O. Kauko
,
+18 authors
J. Westermarck
Cancer Research
2013
Corpus ID: 16601411
Checkpoint kinase Chk1 is constitutively active in many cancer cell types and new generation Chk1 inhibitors show marked…
Expand
2013
2013
CIP2A expression and prognostic role in patients with esophageal adenocarcinoma
T. Rantanen
,
T. Kauttu
,
+5 authors
N. Oksala
Medical Oncology
2013
Corpus ID: 21313311
CIP2A is overexpressed in many cancers, including esophageal squamous cell carcinoma. The regulation of c-MYC and CIP2A…
Expand
2012
2012
CIP2A with survivin protein expressions in human non-small-cell lung cancer correlates with prognosis
P. Xu
,
Xiao-lan Xu
,
Qiang Huang
,
Zhi-hong Zhang
,
Yan-bei Zhang
Medical Oncology
2012
Corpus ID: 20706106
Cancerous inhibitor of protein phosphatase 2A (CIP2A) and survivin are aberrantly expressed in a wide range of human cancers…
Expand
Highly Cited
2012
Highly Cited
2012
Identification of a c-Jun N-terminal kinase-2-dependent signal amplification cascade that regulates c-Myc levels in ras transformation
D. Mathiasen
,
C. Egebjerg
,
+15 authors
T. Kallunki
Oncogene
2012
Corpus ID: 205532448
Ras is one of the most frequently activated oncogenes in cancer. Two mitogen-activated protein kinases (MAPKs) are important for…
Expand
2012
2012
Expression and prognostic significance of CIP2A mRNA in hepatocellular carcinoma and nontumoral liver tissues
Pin-zhu Huang
,
Jiliang Qiu
,
+6 authors
Ruhai Zou
Biomarkers
2012
Corpus ID: 22849209
Objective: This study was undertaken to determine the role of cancerous inhibitor of protein phosphatase 2A (CIP2A) in predicting…
Expand
Review
2011
Review
2011
A Novel SET Antagonist (OP449) Is Cytotoxic to CML Cells, Including the Highly-Resistant BCR-ABLT315I Mutant, and Demonstrates Enhanced Efficacy in Combination with ABL Tyrosine Kinase Inhibitors,
A. Agarwal
,
Ryan J Mackenzie
,
J. Oddo
,
M. Vitek
,
D. Christensen
,
B. Druker
2011
Corpus ID: 208435633
Abstract 3757 Background: The majority of patients with chronic myeloid leukemia (CML) achieve durable remissions with ABL…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE